Tong Dai, MD, Oncology, Buffalo, NY


Oncology Buffalo, NY

Head & Neck Cancer, Thoracic Cancer

Associate Professor/Staff Physician

Dr. Dai is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Dai's full profile

Already have an account?

  • Office

    Roswell Park Comprehensive Cancer Center
    Elm & Carlton Streets
    Buffalo, NY 14263
    Phone(716) 845-3099
    Fax(716) 845-8935
  • Is this information wrong?


  • Tong D. - Associate Professor - Roswell Park | LinkedIn

    View Tong D.'s profile on LinkedIn, the world's largest professional community. Tong has 10 jobs listed on their profile. See the complete profile on LinkedIn a

Education & Training

  • Albert Einstein College of MedicineFellowship, Hematology/Oncology, 2011 - 2014
  • Yale-New Haven HospitalResidency, Internal Medicine, 2008 - 2011
  • Medical College of OhioPh. D., Molecular Basis of Disease, 1998 - 2003
  • Shanghai Medical UniversityClass of 1993
  • Shanghai Medical UniversityDoctor of Medicine (M.D.)

Certifications & Licensure

  • CT State Medical License
    CT State Medical License 2017 - 2021
  • NY State Medical License
    NY State Medical License 2011 - 2022
  • WA State Medical License
    WA State Medical License Current
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Graduate Student Travel Award for Experimental Biology Meeting American Society for Pharmacology and Experimental Therapeutics (ASPET), 2001

Clinical Trials

Publications & Presentations


Journal Articles

  • A phase 2, open-label, study of single agent pembrolizumab in treatment refractory mismatch repair deficient metastatic colorectal cancer: the KEYNOTE-164 study.  
    1. Le D; Kim, TW; Van Cutsem E; Geva R; Jaeger D; Hara H; Burge M; O’Neill B; Kavan P; Yoshino T; Guimbaud R; Taniguchi H; Elez E; Al-Batran SE; Boland PM; Crocenzi T;..., Journal of Clinical Oncology, 8/6/2019
  • The Role of 18F-FDG PET Imaging in Upper Gastrointestinal Malignancies  
    Dai T, Popa E, Shah MA, Curr Treat Options Oncol, 7/27/2014
  • Ruxolitinib Withdrawal Syndrome Leading to Tumor Lysis  
    Dai T, Friedman EW, and Barta SK, Journal of Clinical Oncology, 10/1/2013
  • Join now to see all

Books/Book Chapters


  • A case of malignant nerve sheath tumor presenting as metastatic cancer.
    Dai T, American College of Physicians, Connecticut Chapter, 1/1/2009
  • Role of CEACAM2 in Insulin Action.
    Schroeder-Gloeckler JM, DeAngelis AM, Dai T, Heinrich G, Al-Share QY, et al, American Diabetes Association, Chicago, IL, 1/1/2007
  • Differential role of CEACAM proteins in regulating insulin action.
    Dai T, Kim H-J, Fernstrom MA, Park S-Y, Shulman GI, Kim JK, and Najjar SM, ADA Late-breaking Abstract, New Orleans, LA, 1/1/2003
  • Join now to see all


  • Notch Signaling and Cancer. 
    Denver, CO - 1/1/2009

Professional Memberships

Other Languages

  • Chinese (Mandarin)